Invention Grant
US09562097B2 Use of anti-CD83 agonist antibodies for treating autoimmune diseases
有权
使用抗CD83激动剂抗体治疗自身免疫性疾病
- Patent Title: Use of anti-CD83 agonist antibodies for treating autoimmune diseases
- Patent Title (中): 使用抗CD83激动剂抗体治疗自身免疫性疾病
-
Application No.: US14129053Application Date: 2012-06-29
-
Publication No.: US09562097B2Publication Date: 2017-02-07
- Inventor: Lauri Diehl , Jennifer Bates , Tao Sai
- Applicant: Lauri Diehl , Jennifer Bates , Tao Sai
- Applicant Address: US CA South San Francisco
- Assignee: Genentech, Inc.
- Current Assignee: Genentech, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Morrison & Foerster LLP
- Priority: JP2011-285585 20111227
- International Application: PCT/US2012/045142 WO 20120629
- International Announcement: WO2013/006505 WO 20130110
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
This invention relates to compositions comprising anti-CD83 agonist antibodies and methods of treating autoimmune disorders (such as inflammatory bowel disease) with anti-CD83 agonist antibodies, as well as articles of manufacture comprising anti-CD83 agonist antibodies.
Public/Granted literature
- US20140286950A1 USE OF ANTI-CD83 AGONIST ANTIBODIES FOR TREATING AUTOIMMUNE DISEASES Public/Granted day:2014-09-25
Information query
